Externally Funded Projects

  • Heterogeneity in pancreatic cancer: Kreftforeningen 2020-2025 (CS Verbeke)
  • Effect of neoadjuvant treatment on pancreatic cancer: Helse Sør-Øst 2018-2021 (CS Verbeke)
  • Metabolic rewiring and chemoresistance in pancreatic cancer: Helse Sør-Øst 2019-2022, Family Blix Endowment, and Fondsstiftelsen at Oslo University Hospital (M Amrutkar, CS Verbeke)
  • Expression of DNA repair proteins in ulcerative colitis and colorectal cancer in relation to oxidative and nitrative stress in the intestine: Fondsstiftelsen at Oslo University Hospital (PM De Angelis)
 
Page visits: 866